The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D]pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.
Lipase-catalyzed resolution of racemic 2-alkyl substituted 1-alkanols
作者:Stefan Barth、Franz Effenberger
DOI:10.1016/s0957-4166(00)80120-2
日期:1993.5
(R)-2-alkyl-1-alkanols (R)-1 with high optical purities were obtained by lipase-catalyzed esterification of the racemic substrates (R,S)-1 with vinyl acetate in dichloromethane. The alcohols (R)-1 were oxidized without racemization to the corresponding carboxylic acids (R)-4. The enriched (S)-acetates (S)-3 either were saponified to the alcohols (S)-1 which are substrates for a second lipase-catalyzed transesterification to give (S)-1 in high optical purity or were racemized and applied once again in the kinetic resolution to prepare (R)-1.
VLA-4 INHIBITORS
申请人:DAIICHI PHARMACEUTICAL CO., LTD.
公开号:EP1346982B1
公开(公告)日:2011-09-14
MIDLAND, M. M.;KWON, YOUNG, C., TETRAHEDRON LETT., 1985, 26, N 41, 5013-5016
作者:MIDLAND, M. M.、KWON, YOUNG, C.
DOI:——
日期:——
MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV
申请人:Gilead Sciences, Inc.
公开号:US20170071944A1
公开(公告)日:2017-03-16
Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR8 and pharmaceutically acceptable salts thereof, useful in treating HIV infections.